当前位置:首页 - 行情中心 - 生物股份(600201) - 财务分析

生物股份

(600201)

  

流通市值:119.96亿  总市值:119.96亿
流通股本:11.12亿   总股本:11.12亿

生物股份(600201)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.59亿元,每股收益0.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益565275.49万元,未分配利润332889.59万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产673446.70万元,负债108171.21万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,042,405,531.87619,568,676.18351,572,845.581,255,455,757.88
营业总成本907,899,347.17579,263,137.46283,520,948.561,120,584,380.13
其他经营收益
营业利润179,319,295.9174,365,501.2996,101,587.11124,664,370.53
利润总额179,163,766.8874,149,513.8695,965,459.54124,910,314.79
净利润159,198,803.0558,675,416.4577,202,614.35104,154,092.64
每股收益
其他综合收益95,422,007.8695,500,207.2141,680,353.86-74,369,451.27
综合收益总额254,620,810.91154,175,623.66118,882,968.2129,784,641.37
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,508,564,241.662,103,944,171.382,098,516,975.452,191,397,901.49
非流动资产:
非流动资产合计4,225,902,713.754,467,089,459.694,600,405,574.494,573,271,153.85
资产总计6,734,466,955.416,571,033,631.076,698,922,549.946,764,669,055.34
流动负债:
流动负债合计729,802,631.73753,724,823.25674,370,105.47725,057,916.44
非流动负债:
非流动负债合计351,909,464.23348,591,356.67617,331,994.29624,232,729.53
负债合计1,081,712,095.961,102,316,179.921,291,702,099.761,349,290,645.97
所有者权益(或股东权益):
归属于母公司股东权益合计5,468,925,887.675,370,774,245.955,303,456,826.895,314,336,328.75
股东权益合计5,652,754,859.455,468,717,451.155,407,220,450.185,415,378,409.37
负债和股东权益合计6,734,466,955.416,571,033,631.076,698,922,549.946,764,669,055.34
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,077,694,352.98694,804,292.22303,736,555.431,418,259,007.32
经营活动现金流出小计886,068,992.23605,860,948.63277,518,157.441,128,706,793.22
经营活动产生的现金流量净额191,625,360.7588,943,343.5926,218,397.99289,552,214.1
投资活动产生的现金流量:
投资活动现金流入小计266,150,943.66228,727,470.5913,051,540.38739,784,273.53
投资活动现金流出小计156,189,248.74116,678,394.5567,340,579.771,192,930,451.95
投资活动产生的现金流量净额109,961,694.92112,049,076.04-54,289,039.39-453,146,178.42
筹资活动产生的现金流量:
筹资活动现金流入小计8,486,6705,486,6705,486,67023,251,859.72
筹资活动现金流出小计266,746,462.77261,845,471.0699,973,072.0598,494,962.54
筹资活动产生的现金流量净额-258,259,792.77-256,358,801.06-94,486,402.05-75,243,102.82
汇率变动对现金及现金等价物的影响---1,272.45
现金及现金等价物净增加额43,327,262.9-55,366,381.43-122,557,043.45-238,835,794.69
期末现金及现金等价物余额857,251,636.42758,557,992.09697,642,390.75813,924,373.52
补充资料:
现金及现金等价物的净增加额--55,366,381.43--238,835,794.69
最新报告期:2025-10-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
开源证券王高展,陈雪丽0.170.320.462025-10-28
兴业证券纪宇泽0.120.160.222025-08-28
中金公司王思洋0.180.24--2025-08-25
东兴证券程诗月0.120.210.292025-08-25
开源证券王高展,陈雪丽0.170.320.462025-08-20
TOP↑